cabozantinib
Showing 1 - 25 of 104
Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)
Not yet recruiting
- Castration-resistant Prostate Cancer
- Metastatic Cancer
- Cabozantinib
- Nivolumab
- (no location specified)
Aug 12, 2022
Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma
Active, not recruiting
- Renal Cell Carcinoma
- Cabozantinib
-
Padova, ItalyIstituto Oncologico Veneto
Feb 7, 2022
Pancreatic Cancer Trial in Lexington (Cabozantinib, Pembrolizumab)
Recruiting
- Pancreatic Cancer
- Cabozantinib
- Pembrolizumab
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Feb 26, 2022
Prostate Cancer Trial in Detroit, New York (Cabozantinib)
Recruiting
- Prostate Cancer
- Cabozantinib
-
Detroit, Michigan
- +2 more
Mar 30, 2022
Carcinoma Prostate Trial in Brescia (Cabozantinib)
Recruiting
- Carcinoma Prostate
- Cabozantinib
-
Brescia, ItalyAlfredo Berruti
Mar 2, 2022
Metastatic Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Philadelphia (Cabozantinib)
Recruiting
- Metastatic Renal Cell Carcinoma
- Clear-cell Metastatic Renal Cell Carcinoma
- Cabozantinib
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Mar 2, 2022
Meningioma Trial in Miami (Cabozantinib)
Recruiting
- Meningioma
- Cabozantinib
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc
Jun 17, 2022
Brain Metastases, Renal Cell Carcinoma Trial in Houston (Nivolumab, Ipilimumab, Cabozantinib)
Not yet recruiting
- Brain Metastases
- Renal Cell Carcinoma
- Nivolumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)
Completed
- Prostate Cancer
- Cabozantinib
- Androgen Ablation Therapy
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 23, 2022
Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)
Recruiting
- Neuroblastoma
- +2 more
- Cabozantinib
-
Columbus, OhioNationwide Children's Hospital
Feb 25, 2022
Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)
Recruiting
- Metastatic Hormone Refractory Prostate Cancer
- Cabozantinib
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 6, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Cabozantinib)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Cabozantinib
-
Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
Nov 10, 2022
Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)
Terminated
- Glioblastoma Multiforme
- +3 more
- Cabozantinib
-
Indianapolis, IndianaRiley Hospital for Children at IU Health
Jul 21, 2022
Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange (Cabozantinib, Pembrolizumab)
Recruiting
- Gastric Adenocarcinoma
- GastroEsophageal Cancer
- Cabozantinib
- Pembrolizumab
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Apr 4, 2022
Germ Cell Tumor, Seminoma, Non-seminomatous Germ Cell Tumor Trial in Indianapolis (Cabozantinib)
Recruiting
- Germ Cell Tumor
- +3 more
- Cabozantinib
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Jun 27, 2022
Refractory Cutaneous Melanoma Trial in Portland (Ipilimumab, Nivolumab, Cabozantinib)
Recruiting
- Refractory Cutaneous Melanoma
- Ipilimumab
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Jun 8, 2022
Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Tampa, Atlanta, Salt Lake City (Cabozantinib, Pembrolizumab)
Recruiting
- Metastatic Urothelial Carcinoma
- Bladder Cancer
- Cabozantinib
- Pembrolizumab
-
Tampa, Florida
- +2 more
Jun 9, 2022
Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)
Not yet recruiting
- Advanced Cancer
- Clear Cell Renal Cell Carcinoma
- 177Lu girentuximab
- +3 more
-
Houston, TexasMD Anderson Cancer Center
Dec 15, 2022
High Grade Neuroendocrine Tumors Trial in Saint Louis (Cabozantinib, Blood for plasma biomarkers, Tissue biopsy)
Recruiting
- High Grade Neuroendocrine Neoplasms
- Cabozantinib
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 11, 2021
Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Germany (Cabozantinib)
Recruiting
- Neuroendocrine Tumors
- Neuroendocrine Carcinoma
- Cabozantinib
-
Göttingen, Lower Saxony, Germany
- +5 more
Jun 27, 2022
Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)
Not yet recruiting
- Neuroendocrine Tumors
- Cabozantinib
- Lu-177
-
Portland, OregonProvidence Portland Cancer Institute - Franz Clinic
Feb 10, 2022
Breast Cancer Trial in Boston (Nivolumab, Cabozantinib)
Completed
- Breast Cancer
- Nivolumab
- Cabozantinib
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 29, 2021
Hepatocellular Carcinoma, HCC Trial in Orange (Nivolumab, Ipilimumab, Cabozantinib)
Recruiting
- Hepatocellular Carcinoma
- HCC
- Nivolumab
- +3 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Apr 4, 2022
Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)
Active, not recruiting
- Refractory Soft Tissue Sarcomas
- Cabozantinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 9, 2021
Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors Trial in Boston (Nivolumab, Cabozantinib)
Recruiting
- Carcinoid Tumor
- +2 more
- Nivolumab
- Cabozantinib
-
Boston, Massachusetts
- +1 more
Jan 14, 2022